Jonathan Mayhew, Ontrak CEO, and Dr. Hilary
Placzek, Ontrak Senior Director Medical Economics and Outcomes,
Featured In Most Recent AHIP Program: “How Deeper Engagements Drive
Proven Outcomes”
Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”),
a leading AI-powered and telehealth-enabled, virtualized healthcare
company, today announced that over 200 healthcare decisionmakers
and thought leaders registered with American Health Insurance Plans
(“AHIP”) for the presentation of the landmark behavioral health
study “Treatment Effect of the Ontrak Program” and a discussion of
how the program engages high cost and complex populations with
unaddressed behavioral health conditions and chronic disease,
resulting in proven, durable outcomes and cost savings.
Mr. Mayhew noted in the presentation that Ontrak’s model of
coaching to and through care, drives exceptionally high member
engagement with the program even among those who have failed in
other behavior change programs. Ontrak care coaches guide members
to relevant clinical pathways and providers, and stay connected to
each member throughout the 12-month Ontrak program, to ensure that
social determinants of health are assessed and addressed with the
same level of attention as behavioral health risks.
Dr. Placzek reported that the Treatment Effect study compared a
cohort of Ontrak graduates to a propensity matched control group of
the same size, and found that the Ontrak program delivers a
statistically significant $486 per member per month cost savings,
64% reduction in avoidable inpatient utilization, and a 50%
increase in use of preventive care services, durable 24 months post
enrollment. During the webinar Dr. Placzek also explained how the
impact of app-based digital health programs with short intervention
periods tends to diminish over time, which reinforces foundational
research on program durability. Durable behavior change requires
longer term intervention.
In collaboration with advisors Robert M Kaplan and Jill Glassman
PhD from the Stanford School of Medicine Clinical Excellence
Research Center (CERC), Ontrak expects to submit the Treatment
Effect study for peer review in August and publication in a leading
medical journal.
To access a replay of the “How Deeper Engagements Drive
Impactful, Proven Outcomes” presentation, please visit
https://www.ontrak-inc.com/overcoming-barriers-to-behavioral-health-engagement.
About Ontrak, Inc.
Ontrak, Inc. (f/k/a Catasys, Inc.) is a leading AI and
telehealth enabled, virtualized healthcare company, whose mission
is to help improve the health and save the lives of as many people
as possible. The company’s PRE™ (Predict-Recommend-Engage) platform
predicts people whose chronic disease will improve with behavior
change, recommends effective care pathways that people are willing
to follow, and engages people who are not getting the care they
need. By combining predictive analytics with human engagement,
Ontrak delivers improved member health and validated outcomes and
savings to healthcare payors.
The company’s integrated, technology-enabled Ontrak™ programs, a
critical component of the PRE platform, are designed to provide
healthcare solutions to members with behavioral conditions that
cause or exacerbate chronic medical conditions such as diabetes,
hypertension, coronary artery disease, COPD, and congestive heart
failure, which result in high medical costs. Ontrak has a unique
ability to engage these members, who do not otherwise seek
behavioral healthcare, leveraging proprietary enrollment
capabilities built on deep insights into the drivers of care
avoidance.
A landmark behavioral health study, “Treatment Effect of the
Ontrak Program,” found that Ontrak’s program produces a
statistically significant reduction of 64% in inpatient
hospitalizations within the treatment group of individuals with
untreated behavioral health needs and medical comorbidities. The
program also resulted in an increase in utilization of preventative
behavioral healthcare office visits. The savings for members who
completed the 12-month program were statistically significant and
notable at $486 per member per month, which equates to a savings of
nearly $12,000 per member over two years, post enrollment. The cost
for all-cause health office visits rose $110 per member per month,
a positive change indicating uptake of productive, preventive care
and fewer costly and avoidable inpatient hospitalizations. Advisors
to the Ontrak research team led by Dr. Hilary Placzek include
Robert M Kaplan, faculty member at the Stanford School of Medicine
Clinical Excellence Research Center (CERC) and Jill Glassman PhD,
Biostatistician and Senior Center Manager of Quantitative Analysis
at the Stanford School of Medicine Clinical Excellence Research
Center (CERC).
Ontrak integrates evidence-based psychosocial and medical
interventions delivered either in-person or via telehealth, along
with care coaching and in-market Community Care Coordinators who
address the social and environmental determinants of health,
including loneliness. The company’s programs improve member health
and deliver validated cost savings to healthcare payors.
Learn more at www.ontrak-inc.com
Cautionary Note Regarding Forward-Looking Statements
Except for statements of historical fact, the matters discussed
in this press release are forward-looking and made pursuant to the
Safe Harbor provisions of the Private Securities Litigation Reform
Act of 1995. These forward-looking statements reflect numerous
assumptions and involve a variety of risks and uncertainties, many
of which are beyond our control, which may cause actual results to
differ materially from stated expectations. These risk factors
include, among others, changes in regulations or issuance of new
regulations or interpretations, limited operating history, our
inability to execute our business plan, increase our revenue and
achieve profitability, lower than anticipated eligible members
under our contracts, our inability to recognize revenue, lack of
outcomes and statistically significant formal research studies,
difficulty enrolling new members and maintaining existing members
in our programs, the risk that treatment programs might not be
effective, difficulty in developing, exploiting and protecting
proprietary technologies, intense competition and substantial
regulation in the health care industry, the risks associated with
the adequacy of our existing cash resources and our ability to
continue as a going concern, our ability to raise additional
capital when needed and our liquidity. You are urged to consider
statements that include the words "may," "will," "would," "could,"
"should," "believes," "estimates," "projects," "potential,"
"expects," "plan," "anticipates," "intends," "continues,"
"forecast," "designed," "goal," or the negative of those words or
other comparable words to be uncertain and forward-looking. For a
further list and description of the risks and uncertainties we
face, please refer to our most recent Securities and Exchange
Commission filings which are available on its website at
http://www.sec.gov. Such forward-looking statements are current
only as of the date they are made, and we assume no obligation to
update any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210707005161/en/
Investors: Caroline Paul
Gilmartin Group investors@ontrak-inc.com
Ontrak (NASDAQ:OTRK)
Historical Stock Chart
From Apr 2024 to May 2024
Ontrak (NASDAQ:OTRK)
Historical Stock Chart
From May 2023 to May 2024